Literature DB >> 31371720

Obsessive-compulsive disorder.

Dan J Stein1, Daniel L C Costa2, Christine Lochner3, Euripedes C Miguel2, Y C Janardhan Reddy4, Roseli G Shavitt2, Odile A van den Heuvel5,6, H Blair Simpson7.   

Abstract

Obsessive-compulsive disorder (OCD) is a highly prevalent and chronic condition that is associated with substantial global disability. OCD is the key example of the 'obsessive-compulsive and related disorders', a group of conditions which are now classified together in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and the International Classification of Diseases, 11th Revision, and which are often underdiagnosed and undertreated. In addition, OCD is an important example of a neuropsychiatric disorder in which rigorous research on phenomenology, psychobiology, pharmacotherapy and psychotherapy has contributed to better recognition, assessment and outcomes. Although OCD is a relatively homogenous disorder with similar symptom dimensions globally, individualized assessment of symptoms, the degree of insight, and the extent of comorbidity is needed. Several neurobiological mechanisms underlying OCD have been identified, including specific brain circuits that underpin OCD. In addition, laboratory models have demonstrated how cellular and molecular dysfunction underpins repetitive stereotyped behaviours, and the genetic architecture of OCD is increasingly understood. Effective treatments for OCD include serotonin reuptake inhibitors and cognitive-behavioural therapy, and neurosurgery for those with intractable symptoms. Integration of global mental health and translational neuroscience approaches could further advance knowledge on OCD and improve clinical outcomes.

Entities:  

Mesh:

Year:  2019        PMID: 31371720      PMCID: PMC7370844          DOI: 10.1038/s41572-019-0102-3

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  207 in total

1.  Generic and illness-specific quality of life in obsessive-compulsive disorder.

Authors:  Marit Hauschildt; Lena Jelinek; Sarah Randjbar; Birgit Hottenrott; Steffen Moritz
Journal:  Behav Cogn Psychother       Date:  2010-06-08

Review 2.  An updated meta-analysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder.

Authors:  Dong-Dong Zhou; Wo Wang; Gao-Mao Wang; Da-Qi Li; Li Kuang
Journal:  J Affect Disord       Date:  2017-03-18       Impact factor: 4.839

Review 3.  Obsessive-compulsive disorder: is there a frontal lobe dysfunction?

Authors:  S Khanna
Journal:  Biol Psychiatry       Date:  1988-09       Impact factor: 13.382

4.  Trans-diagnostic comparison of response inhibition in Tourette's disorder and obsessive-compulsive disorder.

Authors:  Siyan Fan; Danielle C Cath; Ysbrand D van der Werf; Stella de Wit; Dick J Veltman; Odile A van den Heuvel
Journal:  World J Biol Psychiatry       Date:  2017-07-25       Impact factor: 4.132

5.  Serotonin reuptake blockers for the treatment of obsessional jealousy.

Authors:  D J Stein; E Hollander; S C Josephson
Journal:  J Clin Psychiatry       Date:  1994-01       Impact factor: 4.384

6.  Mapping structural brain alterations in obsessive-compulsive disorder.

Authors:  Jesús Pujol; Carles Soriano-Mas; Pino Alonso; Narcís Cardoner; José M Menchón; Joan Deus; Julio Vallejo
Journal:  Arch Gen Psychiatry       Date:  2004-07

7.  N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial.

Authors:  K Paydary; A Akamaloo; A Ahmadipour; F Pishgar; S Emamzadehfard; S Akhondzadeh
Journal:  J Clin Pharm Ther       Date:  2016-03-02       Impact factor: 2.512

8.  Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder.

Authors:  Stella J de Wit; Pino Alonso; Lizanne Schweren; David Mataix-Cols; Christine Lochner; José M Menchón; Dan J Stein; Jean-Paul Fouche; Carles Soriano-Mas; Joao R Sato; Marcelo Q Hoexter; Damiaan Denys; Takashi Nakamae; Seiji Nishida; Jun Soo Kwon; Joon Hwan Jang; Geraldo F Busatto; Narcís Cardoner; Danielle C Cath; Kenji Fukui; Wi Hoon Jung; Sung Nyun Kim; Euripides C Miguel; Jin Narumoto; Mary L Phillips; Jesus Pujol; Peter L Remijnse; Yuki Sakai; Na Young Shin; Kei Yamada; Dick J Veltman; Odile A van den Heuvel
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

Review 9.  Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

Authors:  G M Soomro; D Altman; S Rajagopal; M Oakley-Browne
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Efficacy of mindfulness-integrated cognitive behavior therapy in patients with predominant obsessions.

Authors:  Ajay Kumar; Mahendra P Sharma; Janardhanan C Narayanaswamy; Thennarasu Kandavel; Y C Janardhan Reddy
Journal:  Indian J Psychiatry       Date:  2016 Oct-Dec       Impact factor: 1.759

View more
  82 in total

1.  Invasive and Non-invasive Neurostimulation for OCD.

Authors:  Isidoor O Bergfeld; Eva Dijkstra; Ilse Graat; Pelle de Koning; Bastijn J G van den Boom; Tara Arbab; Nienke Vulink; Damiaan Denys; Ingo Willuhn; Roel J T Mocking
Journal:  Curr Top Behav Neurosci       Date:  2021

2.  Aberrant cortico-striatal white matter connectivity and associated subregional microstructure of the striatum in obsessive-compulsive disorder.

Authors:  Hyungyou Park; Minah Kim; Yoo Bin Kwak; Kang Ik K Cho; Junhee Lee; Sun-Young Moon; Silvia Kyungjin Lho; Jun Soo Kwon
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 15.992

Review 3.  Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder.

Authors:  Reilly R Kayser
Journal:  J Clin Psychiatry       Date:  2020-09-08       Impact factor: 4.384

4.  Network-based functional connectivity predicts response to exposure therapy in unmedicated adults with obsessive-compulsive disorder.

Authors:  H Blair Simpson; Rachel Marsh; Tracey C Shi; David Pagliaccio; Marilyn Cyr
Journal:  Neuropsychopharmacology       Date:  2021-01-14       Impact factor: 7.853

5.  Aberrant Resting-State Cerebellar-Cerebral Functional Connectivity in Unmedicated Patients With Obsessive-Compulsive Disorder.

Authors:  Keitaro Murayama; Hirofumi Tomiyama; Sae Tsuruta; Aikana Ohono; Mingi Kang; Suguru Hasuzawa; Taro Mizobe; Kenta Kato; Osamu Togao; Akio Hiwatashi; Tomohiro Nakao
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

Review 6.  Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis.

Authors:  Kaili Liang; Hailong Li; Xuan Bu; Xue Li; Lingxiao Cao; Jing Liu; Yingxue Gao; Bin Li; Changjian Qiu; Weijie Bao; Suming Zhang; Xinyu Hu; Haoyang Xing; Qiyong Gong; Xiaoqi Huang
Journal:  Transl Psychiatry       Date:  2021-05-28       Impact factor: 6.222

7.  Distinct behavioral traits and associated brain regions in mouse models for obsessive-compulsive disorder.

Authors:  Xiao Chen; Jihui Yue; Yuchong Luo; Lianyan Huang; Boxing Li; Shenglin Wen
Journal:  Behav Brain Funct       Date:  2021-05-18       Impact factor: 3.759

8.  Smaller volume of posterior thalamic nuclei in patients with obsessive-compulsive disorder.

Authors:  Jinhyung Jurng; Hyungyou Park; Taekwan Kim; Inkyung Park; Sun-Young Moon; Silvia Kyungjin Lho; Minah Kim; Jun Soo Kwon
Journal:  Neuroimage Clin       Date:  2021-04-21       Impact factor: 4.881

9.  Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample.

Authors:  Humberto Nicolini; José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Jorge Ameth Villatoro Velázquez; Beatriz Camarena; Clara Fleiz Bautista; Marycarmen Bustos-Gamiño; Alejandro Aguilar García; Nuria Lanzagorta; María Elena Medina-Mora
Journal:  Front Psychiatry       Date:  2021-05-10       Impact factor: 4.157

Review 10.  Applications of focused ultrasound in the brain: from thermoablation to drug delivery.

Authors:  Ying Meng; Kullervo Hynynen; Nir Lipsman
Journal:  Nat Rev Neurol       Date:  2020-10-26       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.